medigraphic.com
ISSN 1025-0255 (Electronic)

2016, Number 3

<< Back Next >>

AMC 2016; 20 (3)

Molecular identification of human papilloma virus genotypes in patients with cervical cancer

Piña NJC, Crespo CG, Fando CR, Casanova CG, Curbelo TM, Guerra RMM

Language: Spanish
References: 31
Page: 288-298
PDF size: 713.56 Kb.


ABSTRACT

Background: it is demonstrated that the main cause of cervical cancer is high risk humanp virus. There is no precedent of molecular studies for the typing of Human Papilloma Virus in the population of Camagüey. Polymerase chain reaction is Molecular Biology technique that has been used traditionally for the clinical diagnosis and other purposes. This technique allows confirming the presence of papillomavirus´DNA in the total extracted DNA, from samples of patients with cervical cancer.
Objective: to demonstrate for the first time existing high-risk human papilloma virus genotypes that cause cervical cancer in female population of Camagüey, Cuba.
Methods: a prospective analytic study was conducted, in which 22 female patients of the province of Camagüey were studied. They received medical attention at Ana Betancourt Hospital. Identification and typing of the Human Papilloma Virus genotypes was carried through the molecular procedure Restriction Fragment Length Polymorphism.
Results: patients who presented exophytic lesions accounted for 63, 6%, 4, 5 % had endophytic type, and 31, 8 % presented other types. This study confirmed that high-risk Human Papilloma Virus genotypes existing in the province of Camagüey are genotypes 16 and 31, and the most frequent is 16.
Conclusions: this research is the first report of a molecular study of Human Papilloma Virus from samples of patients with cervical cancer in the province of Camagüey, Cuba. These results, along with the ones obtained by other authors, make an important contribution in the design of the increasingly effective therapeutic and preventive vaccine to an anticipated solution to cervical cancer in Cuba.


REFERENCES

  1. Organización Mundial de la Salud [Internet]. Ginebra: OMS; c1995-2015 [actualizado 12 Ene 2016; citado 4 Jun 2015]. Cervical Cancer Estimated Incidence, Mortality and Prevalence Worldwide in 2012; [aprox. 2 pantallas]. Disponible en: http://globocan.iarc.fr/old/FactSheets/cancers/cervix-new.asp

  2. Domínguez Alonso E, Santana Pérez F, Armando Seuc H, Galán Álvarez Y. Años de vida ajustados por discapacidad por cáncer de mama y del sistema reproductor en mujeres cubanas en edad fértil. MEDICC Review [Internet]. 2014 [citado 10 Sep 2015];selección:[aprox. 7 p.]. Disponible en: http://www.medicc.org/mediccreview/pdf.php?lang=es&id=480

  3. Justin OP, Madhulika V. Cervical cancer and the global health agenda: Insights from multiple policy-analysis frameworks. Global Public Health [Internet]. 2013 [citado 2015 Jun 4];8(10):[about 16 p.]. Available from:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3877944/pdf/rgph8_1093.pdf

  4. Azin N, Maryam H, Ahmad BM, Fatemeh T. A Systematic Review of Economic Aspects of Cervical Cancer screening. Asian Pac J Cancer Prev [Internet]. 2014 [citado 2015 Sep 10];15(19):[about 8 p.]. Available from: http://www.apocpcontrol.org/paper_file/issue_abs/Volume15_No19/8229-8237%206.14%20Azin%20Nahvijou.pdf

  5. Obel J, Souares Y, Hoy D, Baravilala W, Garland SM, Kjaer SK, et al. A Systematic Review of Cervical Cancer Incidence and Mortality in the Pacific Region. Asian Pac J Cancer Prev [Internet]. 2014 [citado 2015 Sep 10];15:[about 4 p.]. Available from: http://www.apocpcontrol.org/paper_file/issue_abs/Volume15_No21/9433-9437%209.12%20Josephine%20Obel.pdf

  6. McGraw SL, Ferrante JM. Update on prevention and screening of cervical cancer. World J Clin Oncol [Internet]. 2014 [citado 2015 Sep 10];5(4):[about 8 p.]. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4129537/pdf/WJCO-5-744.pdf

  7. Ghittoni R, Accardi R, Chiocca S, Tommasino M. Role of human papillomaviruses in carcinogene-sis. Ecancer [Internet]. 2015 [citado 2015 Sep 10];9:[about 7 p.]. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431404/pdf/can-9-526.pdf

  8. Anuario Estadístico de Salud 2013 [Internet]. La Habana: Dirección Nacional de Registros Médicos y Estadísticas de Salud y el Centro Nacional de Información de Ciencias Médicas; 2014 [citado 10 Jun 2015]. Casos positivos de cáncer cérvico-uterino en mujeres examinadas por el programa según etapa clínica. (1990;1995-2013); [aprox. 1 pantalla]. Disponible en: http://files.sld.cu/dne/files/2014/05/anuario-2013-esp-e.pdf

  9. Anuario Estadístico de Salud 2009 [Internet]. La Habana: Dirección Nacional de Registros Médicos y Estadísticas de Salud y el Centro Nacional de Información de Ciencias Médicas; 2010 [citado 10 Jun 2015]. Casos positivos de cáncer cérvico-uterino en mujeres examinadas por el programa según etapa clínica. 1986–2009; [aprox. 1 pantalla]. Disponible en: http://files.sld.cu/bvscuba/files/2013/05/anuario-2009e3.pdf

  10. Anuario Estadístico de Salud 2008 [Internet]. La Habana: Dirección Nacional de Registros Médicos y Estadísticas de Salud y el Centro Nacional de Información de Ciencias Médicas; 2009 [citado 10 Jun 2015]. Casos positivos de cáncer cérvico-uterino detectados en las mujeres examinadas por el programa según etapa clínica. 1985 – 2008; [aprox. 1 pantalla]. Disponible en: http://bvs.sld.cu/cgibin/wxis/anuario/?IsisScript=anuario/iah.xis&tag5001=mostrar^m1865&tag5009=STANDARD&tag5008=10&tag5007=Y&tag5003=anuario&tag5021=e&tag5022=2008&tag5023=1865

  11. Boštjan JK, Anja Š, Lea H, Diego C, Elisa B, Adriana AG, et al. Genome announcement: complete genome sequence of a novel Mupapillomavirus, HPV204. Acta Dermatovenerol APA [Internet]. 2015 [citado 2015 Sep 10];24:[about 3 p.]. Available from: https://s3-eu-west-1.amazonaws.com/thejournalhub/10.15570/actaapa.2015.7/actaapa.2015.7.pdf

  12. Hošnjak L, Kocjan BJ, Pirš B, Seme K, Poljak M. Characterization of Two Novel Gammapapillomaviruses, HPV179 and HPV184, Isolated from Common Warts of a Renal-Transplant Recipient. PLoS ONE [Internet]. 2015 [citado 2015 Nov 8];10(3):[about 18 p.]. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4351898/pdf/pone.0119154.pdf

  13. López-Revilla R. Prevalence of high-risk human papillomavirus types in Mexican women with cervical intraepithelial neoplasia and invasive carcinoma. Infect Agent Cancer [Internet]. 2008 Feb 28 [citado 2015 Oct 9];3(3):[about 12 p.]. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2294112/pdf/1750-9378-3-3.pdf

  14. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med [Internet]. 2003 [citado 2015 Oct 9];348:[about 10 p.]. Available from: http://www.nejm.org/doi/pdf/10.1056/NEJMoa021641

  15. Ghosh SK, Choudhury B, Hansa J, Mondal R, Singh M, Duttagupta S, et al. Human Papillomavirus Testing for Suspected Cervical Cancer Patients from Southern Assam by Fast-PCR. Asian Pacific J Cancer Prev [Internet]. 2011 [citado 2015 Oct 9];12:[about 3 p.]. Available from: http://www.apocpcontrol.org/paper_file/issue_abs/Volume12_No3/749-51%20c%202.8.Sankar%20Kumar%20Ghosh.pdf

  16. Tseng C, Trimble C, Zeng Q, Monie A, Alvarez RD, Huh WK, et al. Low-dose radiation enhances therapeutic HPV DNA vaccination in tumor-bearing hosts. Cancer Immunol Immunother [Internet]. 2009 May [citado 2015 Sep 10];58(5):[about 12 p.]. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2647576/pdf/nihms-70061.pdf

  17. Kim KH, Greenfield WW, Cannon MJ, Coleman HN, Spencer HJ, Nakagawa M. CD4+ T-Cell Response Against Human Papillomavirus Type 16 E6 Protein Is Associated with A Favora-ble Clinical Trend. Cancer Immunol Immunother [Internet]. 2012 Jan [citado 2015 Sep 10];61(1):[about 8 p.]. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3374341/pdf/nihms380403.pdf

  18. Harald ZH, Gissmann L, Schlehofer JR. Viruses in the etiology of human genital cancer. Prog Med Virol. 1984;30:1-17.

  19. The Nobel Prize [Internet]. Suecia: The Official Web site of the nobel prize; c-2016 [actualizado 2016 Abr 12; citado 2015 Sep 11]. The Nobel Prize in Physiology or Medicine 2008; [about 1 pantallas]. Available from: http://www.nobelprize.org/nobel_prizes/medicine/laureates/2008/.

  20. Jairo Amaya G, Restrepo Palacio S. Tamizaje para cáncer de cuello uterino: cómo, desde y hasta cuándo. Rev Colomb Obstet Ginecol [Internet]. 2005 [citado 9 Oct 2015];56(1):[aprox. 8 p.]. Disponible en: http://www.scielo.org.co/pdf/rcog/v56n1/v56n1a07.pdf

  21. Hesselink AT, Berkhof J, van der Salm ML, van Splunter AP, Geelen TH, van Kemenade FJ, et al. Clinical Validation of the HPV-Risk Assay, a Novel Real-Time PCR Assay for Detection of High-Risk Human Papillomavirus DNA by Targeting the E7 Region. J Clin Microbiol [Internet]. 2014 [citado 2015 Sep 10];52(3):[about 7 p.]. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3957775/pdf/zjm890.pdf

  22. Eklund C, Forslund O, Wallin K-L, Dillner J. Global Improvement in Genotyping of Human Papillomavirus DNA: the 2011 HPV LabNet International Proficiency Study. J Clin Microbiol [Internet]. 2014 [citado 2015 Sep 10];52(2):[about 11 p.]. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3911320/pdf/zjm449.pdf

  23. Promega Corporation [Internet]. Madison: Promega; 2013 [update 2016 Abr 12; citado 2013 Jan 15]. Wizard SV Genomic DNA Purification System (Technical Bulletin) 2009; [about 16 pantallas]. Available from: http://www.promega.com/%7E/media/files/resources/protocols/technical%20bulletins/101/wizard%20sv%20genomic%20dna%20purification%20system%20protocol.pdf?la=en

  24. Gravitt PE, Peyton CL, Alessi T, Wheeler CM, Coutlee F, Hildeshe A, et al. Improved Amplification of Genital Human Papillomaviruses. J Clin Microbiol [Internet]. 2000 Jan [citado 2015 Oct 9];38(1):[about 4 p.]. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC88724/pdf/jm000357.pdf

  25. National Center for Biotechnology Information [Internet]. Bethesda MD: NCBI; [update 2016 Mar 11; citado 2013 Jan 16]. Genbank; [about 1 screens]. Available from: http://www.ncbi.nlm.nih.gov/genbank/.

  26. National Center for Biotechnology Information [Internet]. Bethesda MD: NCBI; [update 2016 Mar 11; citado 2016 Feb 7]. BLAST; [about 1 screens]. Available from: http://www.ncbi.nlm.nih.gov/BLAST/.

  27. Bruni L, Diaz M, Castellsagué M, Ferrer E, Bosch FX, de Sanjosé S. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis [Interet]. 2010 [citado 2015 Nov 8];202:[about 11 p.]. Available from: http://jid.oxfordjournals.org/content/202/12/1789.full.pdf+html

  28. Ríos Hernández MA, Hernández Menéndez M, Aguilar Vela de Oro FO, Silveira Pablos M. Tipos de papilomavirus humanos más frecuentes en muestras cubanas de cáncer cervical. Rev Cubana Obstet Ginecol [Internet]. 2010 [citado 9 Oct 2015];36(2):[aprox. 8 p.]. Disponible en: http://scielo.sld.cu/pdf/gin/v36n2/gin09210.pdf

  29. Soto Y, Muné M, Goicolea A, Morales E, Santoyo JM, Valdés O, et al. Aplicación de la técnica de reacción en cadena de la polimerasa para la detección de secuencias de Papillomavirus humano. Rev Cubana Med Trop [Internet]. 1998 [citado 11 jun 2015];50(3):[aprox. 9 p.]. Disponible en: http://www.bvs.sld.cu/revistas/mtr/vol50_3_98/mtr04398.pdf

  30. Soto Brito Y, Kourí Cardellá V, Martínez Ro-dríguez PA, Correa Sierra C. Normalización de un sistema de reacción en cadena de la polime-rasa en tiempo real para la cuantificación de pa-pilomavirus humano de alto riesgo oncogénico. VacciMonitor [Internet]. 2012 [citado 12 Oct 2015];21(1):[aprox. 7 p.]. Disponible en: http://scielo.sld.cu/pdf/vac/v21n1/vac07112.pdf

  31. Serra Valdés MA, Fojo Mallo AW, González Valera N, Cardosa Samón M, García Tassé M, Aleaga Hernández YY. Infección por papilomavirus humano y cáncer esofágico: reporte de caso. Medwave [Internet]. Oct 2012[citado 11 Jun 2015];12(9):[aprox. e5531 p.]. Disponible en: http://www.medwave.cl/link.cgi/Medwave/Estudios/Casos/5531?ver=sindiseno




2020     |     www.medigraphic.com